Teva Takeda to License 10 APIs/20 Products from Sawai as It Plans to Shutter In-House Plants

August 21, 2019
Teva Takeda Pharma, a Japanese joint venture of Takeda Pharmaceutical and Teva Pharmaceuticals Industries, will license 10 APIs/20 products from Sawai Pharmaceutical, bracing for its upcoming closure of two plants that are currently manufacturing 31 APIs/61 products. The move is...read more